InterCure Ltd. INCR
3.89 USD -0.13 (-3.23%)
Nov 4, 2026, 9:30 AM EST
3.89 Day range 3.89
3.40 52-week range 7.55
- YTD
- -14.51%
- 1 year
- -46.71%
- Market cap
- 58.36M
- Revenue (ttm)
- 272.67M
- Profit margin
- -24.07%
- EPS (ttm)
- -0.94
- Shares out
- 45.77M
- Forward P/E
- -1.21
- YTD return
- -14.51%
- 1-year return
- -46.71%
- Volume
- 387
- Avg volume
- 22.38K
- Open
- 3.89
- Previous close
- 4.02
- Day's range
- 3.89 – 3.89
- 52-week range
- 3.40 – 7.55
- Beta
- 0.03
2Y -4.66 (-53.69%)
Key statistics
- Enterprise value
- 203.36M
- PEG ratio
- 0.00
- Price / sales
- 0.30
- Price / book
- 0.19
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -38.60%
- Free cash flow
- 0
- Total cash
- 20.30M
- Total debt
- 150.81M
- Return on equity
- -13.61%
- Short % of float
- 0.15%
- 50-day average
- 1.52
- 200-day average
- 2.14
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
INCR Revenue — quarterly 102.44M
INCR Net income — quarterly 4.88M
INCR EPS — quarterly 0.525
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 31, 2023 | Jun 1, 2023 | 0.00 | 0.03 | — | — |
| May 15, 2023 | Mar 1, 2023 | 0.00 | 0.00 | — | — |
| Mar 31, 2023 | Dec 1, 2022 | 0.00 | 0.05 | — | — |
| Nov 15, 2022 | Sep 1, 2022 | 0.00 | 0.05 | — | — |
| Aug 15, 2022 | Jun 1, 2022 | 0.00 | 0.10 | — | — |
| May 16, 2022 | Mar 1, 2022 | 0.00 | 0.11 | — | — |
About InterCure Ltd.
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Israel
- Website
- intercure.co
News
InterCure Regains Nasdaq Compliance 
InterCure Enters Private Placement With Its CEO And Other Shareholders For Commitments Of ~$7.4M, With Option To Increase To ~$18.6M 
12 Health Care Stocks Moving In Friday's Intraday Session - 12 Health Care Stocks Moving In Monday's Pre-Market Session
Trump's Marijuana Reclassification Looks Set To Send This Cannabis ETF Soaring: Big Surge In Momentum 
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report 
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report 
Watching Cannabis Stocks; Marijuana Moment Reports 'Trump White House Invites Proposal On Federal Marijuana Legalization, Activist Says' - Stocks That Hit 52-Week Lows On Friday
- Stocks That Hit 52-Week Lows On Thursday
Your note
Sign in to keep a note on INCR — it syncs with the Stock Master app.